13 July, 2017
(NYSE:MRK) announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on KEYNOTE-183, KEYNOTE-185 and KEYNOTE-023, three combination studies of KEYTRUDA® (pembrolizumab), the company's anti-PD-1 therapy, in the blood cancer multiple myeloma. The lowest EPS estimate is ($0.20) and the highest is ($0.14).
Quarterly Revenue growth year over year is 14.6 Percent.
Director at Precision Drilling Corporation, Meyers, Kevin Omar on 2014-12-10 Buy 2500 shares of the company at a price of $5.45. Precision Drilling Corporation earned a media sentiment score of 0.28 on Accern's scale.
12/14/2016 - Citigroup began new coverage on Precision Drilling Corporation giving the company a "neutral" rating.
The stock is now moving with a Negative distance from 200-Day Simple Moving Average of about -32.16% and has no so good Year to Date (YTD) Performance of -42.57% which means the stock is constantly adding to its value from previous fiscal year end price. Bank of America Corp DE boosted its position in shares of Precision Drilling Corporation by 138.6% in the first quarter. For the next fiscal year, analysts anticipate that the business will report earnings of ($0.02) per share, with EPS estimates ranging from ($0.11) to $0.08.
PD has been the discussion subject of Quite a few brokerage firm research. During the same period a year ago, the firm earned ($0.07) EPS. Also, insider Glen Fleming acquired 400,000 shares of the business's stock in a transaction that occurred on Thursday, June 15th.
Several hedge funds have recently made changes to their positions in the stock. On the other side, analysts now consider Precision Drilling Corporation a buy, and a technical analysis of the stock is setting somewhat neutral outlook for now. AXA now owns 108,713 shares of the oil and gas company's stock worth $513,000 after buying an additional 58,890 shares during the period. The company's stock had a trading volume of 9,200 shares. Vanguard Group Inc. increased its stake in shares of Precision Drilling Corporation by 6.4% in the first quarter. The oil and gas company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.05. Finally, Deutsche Bank AG increased their price objective on Precision Drilling Corporation from $8.00 to $10.00 and gave the company a "buy" rating in a report on Tuesday, April 25th. The stock of Precision Drilling Corp (USA) (NYSE:PDS) has "Outperform" rating given on Wednesday, April 26 by Raymond James. The stock has an average rating of "Buy" and a consensus price target of $6.44.
While having a peek at profitability ratios Precision Drilling Corp (NYSE:PDS) has trailing twelve month gross margin at 32.5%, its trailing twelve month operating margin stands at -17.4% whereas its trailing twelve month net profit margin spots at -15.9%. Institutional investors own 63.24% of the company's stock. TD Asset Management Inc. now owns 5,500,185 shares of the oil and gas company's stock valued at $25,942,000 after buying an additional 736,820 shares in the last quarter.
Precision Drilling Corporation (NYSE PDS) traded up 1.136% during mid-day trading on Friday, hitting $3.115. If you are accessing this article on another domain, it was stolen and republished in violation of United States & worldwide copyright & trademark legislation.
The current market capitalization of Precision Drilling Corp (NYSE:PDS) stands at 861.38 Million. The firm exchanged a volume of 6.69 million shares at hands. Precision Drilling has a 12-month low of $3.77 and a 12-month high of $8.21. The Completion and Production Services segment offers completion and workover services, and ancillary services to oil and natural gas exploration and production companies.
